Drugs News and Research

RSS

Teplizumab to block type 1 diabetes proves strikingly effective in phase 2 clinical trial

An experimental drug designed to block the advance of type 1 diabetes in its earliest stages has proven strikingly effective over two years in about half of the patients who participated in the phase 2 clinical trial.

8 Aug 2013

Brain tumor cells in arrested development contribute to cell variety that protects cancer

A program that pushes immature cells to grow up and fulfill their destiny as useful, dedicated cells is short-circuited in the most common and deadly form of brain tumor, scientists at The University of Texas MD Anderson Cancer Center report this week in the Early Edition of the Proceedings of the National Academy of Sciences.

8 Aug 2013

Some states say they won't enforce the health law's insurance reforms

Six states have taken this position, according to the Texas Tribune. Meanwhile, media outlets report on new developments regarding state activity on the health law's Medicaid expansion and health exchanges.

8 Aug 2013

Nearly 59% of liver transplant patients experience metabolic syndrome

Nearly 59 percent of liver transplant patients experience metabolic syndrome, which increases the risk of heart disease, stroke and diabetes, according to a study lead by liver specialist Eric R. Kallwitz, MD, of Loyola University Medical Center.

8 Aug 2013

Researchers develop nanoprobe technique to help treat fatal diseases more effectively

Researchers at the University of Southampton, in collaboration with colleagues at the University of Cambridge, have developed a technique to help treat fatal diseases more effectively.

8 Aug 2013

Cancer-linked mitosis: an interview with Professor Scott Kern, Johns Hopkins University School of Medicine

Mitosis is the process by which a cell gives rise to two daughter cells. It’s the basis behind the growth of the human body, the renewal of the human body as it ages, and unfortunately, the growth of cancers.

7 Aug 2013

New clinical protocols, guidelines for mental health care after trauma and loss

The World Health Organization is releasing new clinical protocols and guidelines to health care workers for treating the mental health consequences of trauma and loss.

7 Aug 2013

Study could boost development of personalised medicine in cancer care and therapy

A team of scientists led by Associate Professor Zeng Qi from A*STAR's Institute of Molecular and Cell Biology have discovered a new biomarker which will help physicians predict how well cancer patients respond to cancer drugs. Having the means to identify patients who are most likely to benefit from currently available cancer drugs not only reduces substantially the healthcare cost for the patient, it could mean saving precious lives by getting the right drugs to the right patient at the onset of the treatment.

7 Aug 2013

First Edition: August 7, 2013

Today's headlines include reports about how deadlines have been missed regarding tests for the health cxchange privacy system.

7 Aug 2013

New guidelines for treating mental health consequences of trauma and loss

WHO is releasing new clinical protocols and guidelines to health-care workers for treating the mental health consequences of trauma and loss.

7 Aug 2013

Viewpoints: Health law's marketing challenge; GOP not to blame for implementation challenges

More than half of working-class whites say [the federal health law] is a bad idea. Perhaps most stunningly, so do 48% of those currently without health insurance - the very people who stand to gain the most, in the form of help finding and paying for coverage. Meanwhile, by a 30-point margin, political independents think they will be worse off under the law.

7 Aug 2013

Findings may allow lower doses of chemotherapy, limit toxic side effects

In research recently published in Nature Structural & Molecular Biology, Alessandro Vindigni, Ph.D., associate professor of biochemistry and molecular biology at Saint Louis University, discovered how cancer cells respond to the damage caused by an important class of anti-cancer drugs, topoisomerase I inhibitors.

7 Aug 2013

Expansion of heroin, opioid medical treatment needed to reduce overdose deaths

A new report from Simon Fraser University researcher Bohdan Nosyk calls for the expansion of heroin and opioid medical treatment to stem the increase of overdose deaths.

7 Aug 2013

Scientists discover biomarker that helps physicians predict how well cancer patients respond to drugs

A team of scientists led by Associate Professor Zeng Qi from A*STAR's Institute of Molecular and Cell Biology (IMCB) have discovered a new biomarker which will help physicians predict how well cancer patients respond to cancer drugs.

7 Aug 2013

Immune function restored in spinal injured mice

In a new study, researchers at The Center for Brain and Spinal Cord Repair at The Ohio State University Wexner Medical Center show that is possible to restore immune function in spinal injured mice.

7 Aug 2013

SmartTots announces recipients of pediatric anesthesia research grants

SmartTots announces Lena Sun, MD and Jeffrey William Sall, PhD, MD as the recipients of its 2013/2014 round of pediatric anesthesia research grants. The research grants are intended to support investigations into the existence of a clinical signal suggesting poor neurocognitive outcomes as the result of early exposure to anesthesia.

7 Aug 2013

Updated United States Public Health Service guidelines for management of occupational exposure to HIV

New guidelines from the United States Public Health Service update the recommendations for the management of healthcare personnel with occupational exposure to HIV and use of postexposure prophylaxis.

7 Aug 2013

Combining drugs that target AXL and ErbB receptors could offer better way to fight tumors

Cancer drugs known as ErbB inhibitors have shown great success in treating many patients with lung, breast, colon and other types of cancer. However, ErbB drug resistance means that many other patients do not respond, and even among those who do, tumors commonly come back.

7 Aug 2013

Genetic variations in genes could put patients at risk for statin-associated muscle injury: Study

Statins, a class of drugs used to lower cholesterol, are among the best selling drugs in North America and around the world. However, statin myopathy, which results in muscle pain and weakness, is a common side effect affecting up to 10 percent of statin users. A recent study led by Dr. Richard Kim of the Lawson Health Research Institute, in collaboration with Dr. Robert Hegele of Robarts Research Institute, and researchers from Vanderbilt University, found that commonly occurring genetic variations in a person's genes could put them at risk for statin-associated muscle injury.

7 Aug 2013

UCLA researchers combine cellular and gene therapies to develop treatment for breast cancer

Researchers at UCLA's Jonsson Comprehensive Cancer Center have successfully combined cellular therapy and gene therapy in a mouse-model system to develop a viable treatment strategy for breast cancer that has spread to a patient's brain.

7 Aug 2013

Drugs News and Research

Teplizumab to block type 1 diabetes proves strikingly effective in phase 2 clinical trial

Brain tumor cells in arrested development contribute to cell variety that protects cancer

Some states say they won't enforce the health law's insurance reforms

Nearly 59% of liver transplant patients experience metabolic syndrome

Researchers develop nanoprobe technique to help treat fatal diseases more effectively

Cancer-linked mitosis: an interview with Professor Scott Kern, Johns Hopkins University School of Medicine

New clinical protocols, guidelines for mental health care after trauma and loss

Study could boost development of personalised medicine in cancer care and therapy

First Edition: August 7, 2013

New guidelines for treating mental health consequences of trauma and loss

Viewpoints: Health law's marketing challenge; GOP not to blame for implementation challenges

Findings may allow lower doses of chemotherapy, limit toxic side effects

Expansion of heroin, opioid medical treatment needed to reduce overdose deaths

Scientists discover biomarker that helps physicians predict how well cancer patients respond to drugs

Immune function restored in spinal injured mice

SmartTots announces recipients of pediatric anesthesia research grants

Updated United States Public Health Service guidelines for management of occupational exposure to HIV

Combining drugs that target AXL and ErbB receptors could offer better way to fight tumors

Genetic variations in genes could put patients at risk for statin-associated muscle injury: Study

UCLA researchers combine cellular and gene therapies to develop treatment for breast cancer

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News